Document Detail


Contractile responses to histamine, serotonin, and angiotensin II are impaired by 17 beta-estradiol in human internal mammary arteries in vitro.
MedLine Citation:
PMID:  9127439     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is accumulating evidence that estrogen replacement therapy protects against the development of coronary atherosclerosis and myocardial infarction in postmenopausal women. The mechanism of this protective effect is uncertain. The purpose of the present study was to determine whether 17 beta-estradiol acutely modifies vascular smooth muscle contractile responses to various agonists in human arteries in vitro. Human mammary artery rings were obtained during aortocoronary bypass operations. Rings were suspended in organ baths for isometric tension measurements. Concentration response curves induced by serotonin (0.01-30 mumol/l), histamine (0.01-300 mumol/l), and angiotensin II (0.1-100 nmol/l) were generated after pre-incubation for 30 min with either 17 beta-estradiol (3 mumol/l) or solvent (0.2% ethanol). The presence of 17 beta-estradiol significantly reduced the maximal contractile effects induced by histamine, serotonin, and angiotensin II, but not by 80 mmol/l potassium chloride. It is concluded that short-term incubation with 17 beta-estradiol reduces the maximal contractile responses to serotonin, histamine, and angiotensin II. These modulating effects of estrogen on vascular tone may contribute to the proposed beneficial role of estrogen replacement therapy on the incidence of myocardial infarction in postmenopausal women.
Authors:
A Mügge; M Barton; H G Fieguth; M Riedel
Related Documents :
7169169 - Inotropic and electrophysiological effects of tolbutamide in normal subjects.
23635919 - Isolated bilateral middle cerebellar peduncle infarcts.
3958379 - Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditi...
25082579 - Life-threatening events during endurance sports: is heat stroke more prevalent than arr...
24956189 - Impact of left ventricular hypertrophy on qt prolongation and associated mortality.
7260239 - Antagonism of doxorubicin cardiotoxicity by carnitine is specific of the l-diasteroisomer.
17123649 - Large recesses associated with left ventricular noncompaction: an unusual presentation ...
15770429 - Pyrroloquinoline quinone (pqq) decreases myocardial infarct size and improves cardiac f...
2598949 - Probability of a return to work after either coronary balloon dilatation or coronary by...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Pharmacology     Volume:  54     ISSN:  0031-7012     ISO Abbreviation:  Pharmacology     Publication Date:  1997 Mar 
Date Detail:
Created Date:  1997-07-10     Completed Date:  1997-07-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0152016     Medline TA:  Pharmacology     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  162-8     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Hannover Medical School, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Angiotensin II / pharmacology*
Coronary Artery Bypass
Dose-Response Relationship, Drug
Estradiol / pharmacology*
Estrogen Replacement Therapy
Female
Histamine / pharmacology*
Humans
Male
Mammary Arteries / drug effects,  metabolism
Middle Aged
Muscle Contraction / drug effects
Muscle, Smooth, Vascular / drug effects*,  metabolism
Potassium Chloride / adverse effects
Serotonin / pharmacology*
Chemical
Reg. No./Substance:
11128-99-7/Angiotensin II; 50-28-2/Estradiol; 50-67-9/Serotonin; 51-45-6/Histamine; 7447-40-7/Potassium Chloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Activation-secretion coupling in 10P2 murine mast cells challenged with IgE-antigen, ionophore A2318...
Next Document:  Automatic system for measuring dose-area product (DAP) in ROI fluoroscopy.